1. Home
  2. BOLD vs HUBC Comparison

BOLD vs HUBC Comparison

Compare BOLD & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • HUBC
  • Stock Information
  • Founded
  • BOLD 2018
  • HUBC 2017
  • Country
  • BOLD United States
  • HUBC Israel
  • Employees
  • BOLD N/A
  • HUBC N/A
  • Industry
  • BOLD
  • HUBC
  • Sector
  • BOLD
  • HUBC
  • Exchange
  • BOLD Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • BOLD 24.4M
  • HUBC 25.1M
  • IPO Year
  • BOLD 2024
  • HUBC N/A
  • Fundamental
  • Price
  • BOLD $1.15
  • HUBC $2.37
  • Analyst Decision
  • BOLD Buy
  • HUBC
  • Analyst Count
  • BOLD 4
  • HUBC 0
  • Target Price
  • BOLD $4.00
  • HUBC N/A
  • AVG Volume (30 Days)
  • BOLD 77.7K
  • HUBC 352.6K
  • Earning Date
  • BOLD 11-06-2025
  • HUBC 11-11-2025
  • Dividend Yield
  • BOLD N/A
  • HUBC N/A
  • EPS Growth
  • BOLD N/A
  • HUBC N/A
  • EPS
  • BOLD N/A
  • HUBC N/A
  • Revenue
  • BOLD N/A
  • HUBC $29,562,000.00
  • Revenue This Year
  • BOLD N/A
  • HUBC N/A
  • Revenue Next Year
  • BOLD N/A
  • HUBC N/A
  • P/E Ratio
  • BOLD N/A
  • HUBC N/A
  • Revenue Growth
  • BOLD N/A
  • HUBC N/A
  • 52 Week Low
  • BOLD $1.00
  • HUBC $1.72
  • 52 Week High
  • BOLD $4.72
  • HUBC $14.00
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 49.88
  • HUBC 47.20
  • Support Level
  • BOLD $1.13
  • HUBC $1.93
  • Resistance Level
  • BOLD $1.16
  • HUBC $2.77
  • Average True Range (ATR)
  • BOLD 0.04
  • HUBC 0.20
  • MACD
  • BOLD 0.00
  • HUBC 0.05
  • Stochastic Oscillator
  • BOLD 55.56
  • HUBC 52.38

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: